scutellarin has been researched along with Hyperlipemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, J; Fan, H; Kang, Q; Li, Y; Lin, P; Ma, X; Sun, D; Wang, L; Zhao, Z | 1 |
| Chen, P; He, B; Li, F; Mo, J; Shen, Z; Yang, R; Zhang, X; Zhang, Y | 1 |
2 other study(ies) available for scutellarin and Hyperlipemia
| Article | Year |
|---|---|
Scutellarin Prevents Nonalcoholic Fatty Liver Disease (NAFLD) and Hyperlipidemia via PI3K/AKT-Dependent Activation of Nuclear Factor (Erythroid-Derived 2)-Like 2 (Nrf2) in Rats.
Topics: Animals; Antioxidants; Apigenin; Diet, High-Fat; Glucuronates; Hyperlipidemias; Lipid Metabolism; Liver; Male; NF-E2-Related Factor 2; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Triglycerides | 2017 |
Scutellarin protects against vascular endothelial dysfunction and prevents atherosclerosis via antioxidation.
Topics: Animals; Antioxidants; Apigenin; Atherosclerosis; Diet, High-Fat; Endothelium, Vascular; Female; Glucuronates; Glutathione Peroxidase; Human Umbilical Vein Endothelial Cells; Humans; Hydrogen Peroxide; Hyperlipidemias; Male; Oxidative Stress; Protective Agents; Rabbits; Rats, Sprague-Dawley; Reactive Oxygen Species; Superoxide Dismutase | 2018 |